Study of AK-1286 in adults with advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called AK-1286 for people with advanced solid tumors who have not responded to or could not tolerate standard treatments. The goal is to see how safe and effective the drug is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed advanced solid tumor that has gotten worse after standard treatment or you cannot have those treatments.
- You are expected to live at least 3 more months.
- You are able to get around and take care of yourself (ECOG 0 or 1).
- Your blood counts, liver, and kidney function are within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This Phase 1 study tests AK129 in people with advanced cancers that have spread. It looks for a safe dose and early signs the treatment may work, especially for tumors with measurable disease and needed prior treatment options.
This trial tests a new drug called AK132 for people with advanced solid tumors. It looks at safety and how well the drug works, and may be an option if you have not already tried treatments targeting CD47 or Claudin18.2.
This trial tests a new drug called AK138D1 for people with advanced solid tumors. It aims to see if the drug is safe and how well it works, especially for tumors that haven't been treated with HER3-targeted therapy before.
This trial tests a new drug called AK131 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and can help slow or shrink the cancer.
This trial tests a new drug called AK138D1 for people with advanced solid tumors that have not responded to or can't tolerate standard treatments. The goal is to see if it is safe and effective.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.